Merit M Tabbers1, Nicole Boluyt, Marjolein Y Berger, Marc A Benninga. 1. Department of Paediatric Gastroenterology and Nutrition, Emma Children's Hospital/Academic Medical Centre, H7-250, PO Box 22700, 1100 DD, Amsterdam, the Netherlands. m.m.tabbers@amc.nl
Abstract
UNLABELLED: Childhood functional constipation has an estimated prevalence of 3% in the Western world and is probably the most common gastrointestinal complaint in children. It is characterized by infrequent painful defecation, faecal incontinence and abdominal pain. Only less than 5% of children with constipation have an underlying disease. Only recently two evidence-based guidelines (the Netherlands and Great Britain) have been developed concerning the diagnostic and therapeutic approach for childhood constipation which we both discuss in this article. At present, a thorough medical history and complete physical exam are usually sufficient to confirm the diagnosis of functional constipation. Further laboratory or radiological investigations should only be performed in case of doubt, to exclude an underlying disease. Treatment of childhood constipation consists of four steps: (1) education, (2) disimpaction, (3) prevention of re-accumulation of faeces and (4) follow-up. Surprisingly, there is only limited evidence that laxative treatment is better than placebo in children with constipation. However, according to the available evidence, the Dutch guideline recommends lactulose for children <1 year as first-choice treatment. For children below the age of older than 1 year, both lactulose and polyethylene glycol (PEG) with or without electrolytes can be used as first-choice treatment. According to the National Institute for Health and Clinical Excellence guideline, PEG plus electrolytes is the first-choice treatment for all ages. CONCLUSION: Children with functional constipation should be diagnosed and treated according to recently developed evidence-based guidelines.
UNLABELLED: Childhood functional constipation has an estimated prevalence of 3% in the Western world and is probably the most common gastrointestinal complaint in children. It is characterized by infrequent painful defecation, faecal incontinence and abdominal pain. Only less than 5% of children with constipation have an underlying disease. Only recently two evidence-based guidelines (the Netherlands and Great Britain) have been developed concerning the diagnostic and therapeutic approach for childhood constipation which we both discuss in this article. At present, a thorough medical history and complete physical exam are usually sufficient to confirm the diagnosis of functional constipation. Further laboratory or radiological investigations should only be performed in case of doubt, to exclude an underlying disease. Treatment of childhood constipation consists of four steps: (1) education, (2) disimpaction, (3) prevention of re-accumulation of faeces and (4) follow-up. Surprisingly, there is only limited evidence that laxative treatment is better than placebo in children with constipation. However, according to the available evidence, the Dutch guideline recommends lactulose for children <1 year as first-choice treatment. For children below the age of older than 1 year, both lactulose and polyethylene glycol (PEG) with or without electrolytes can be used as first-choice treatment. According to the National Institute for Health and Clinical Excellence guideline, PEG plus electrolytes is the first-choice treatment for all ages. CONCLUSION:Children with functional constipation should be diagnosed and treated according to recently developed evidence-based guidelines.
Authors: Marc Benninga; David C A Candy; Anthony G Catto-Smith; Graham Clayden; Vera Loening-Baucke; Carlo Di Lorenzo; Samuel Nurko; Annamaria Staiano Journal: J Pediatr Gastroenterol Nutr Date: 2005-03 Impact factor: 2.839
Authors: Samuel Nurko; Nader N Youssef; Mahmoud Sabri; Annette Langseder; John McGowan; Mark Cleveland; Carlo Di Lorenzo Journal: J Pediatr Date: 2008-03-19 Impact factor: 4.406
Authors: Wieger P Voskuijl; Jarom Heijmans; Hugo S A Heijmans; Jan A J M Taminiau; Marc A Benninga Journal: J Pediatr Date: 2004-08 Impact factor: 4.406
Authors: M A Thomson; H R Jenkins; W M Bisset; R Heuschkel; D S Kalra; M R Green; D C Wilson; M Geraint Journal: Arch Dis Child Date: 2007-07-11 Impact factor: 3.791
Authors: Marloes E J Bongers; Marc A Benninga; Heleen Maurice-Stam; Martha A Grootenhuis Journal: Health Qual Life Outcomes Date: 2009-03-02 Impact factor: 3.186